ClinicalTrials.gov · NCT07293325 · Recruiting
Semaglutide and Tirzepatide for Genetic Aging Delay in Adults With Obesity
Registry record
NCT07293325 on ClinicalTrials.gov. The registry's last update to this record was 19 December 2025.
Verification record
5 checked · 0 company says · 0 reported · 0 not found · 0 not yet checked
- Title as registered Semaglutide and Tirzepatide for Genetic Aging Delay in Adults With Obesity Checked Source clinicaltrials.gov Brief title as registered. Checked
- Sponsor Second Affiliated Hospital, Zhejiang University, School of Medicine Checked Source clinicaltrials.gov Lead sponsor as registered. Checked
- Intervention Semaglutide; Tirzepatide; Metformin Checked Source clinicaltrials.gov Intervention names as registered. Checked
- Primary outcome as registered Change in DNA methylation-based biological age measured by iWatchAge Checked Source clinicaltrials.gov Primary outcome measure(s) as registered. Checked
- Status Recruiting Checked Source clinicaltrials.gov Overall status as registered; registry last update 2025-12-19. Checked
Check history: NCT07293325 was last read on the registry on November 14, 2026. No earlier checks are recorded. How records are checked.
Corrections: none recorded for this trial. To ask for one, write to [email protected] with the registry number; every correction is checked against the registry record before the record changes.
As registered
- Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
- Phase: Not applicable
- Status: Recruiting
- Intervention: Semaglutide; Tirzepatide; Metformin
- Primary outcome: Change in DNA methylation-based biological age measured by iWatchAge
- Countries: China
- Start: 2 June 2025
- Completion (estimated): 2 June 2027
Results
No results were posted on the registry on the date checked. The Atlas does not summarize findings.